BRVE

Braveheart Bio, Inc.

Healthcare Pharmaceutical Preparations Market cap: not available All insider activity → Quote and statistics → Sign in to watch BRVE Sign in to set a price alert

AI summary Insiders and major institutional backers buy shares in Braveheart Bio's initial public offering at $18.00.

Insider Score Band 60–79

Research score: 77
AI adjustment: -11

Research score, not a recommendation.

Total bought$159.0M13 Form 4 purchases

Distinct insiders10open-market buyers

Lead insiderMurdoch TravisCEO

Cluster window2026-08-07single day · active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

partial data Market cap is missing; missing inputs count as neutral in the score.

same price, one day All 13 purchases were at $18.00 on 2026-08-07. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders

100%

Seniority executive rank of buyers (CEO/CFO/Director)

80%

Commitment purchase size relative to company & holdings

53%

Context buying into stock weakness signals conviction

50%

Timing coordinated purchases within a tight window

100%

Routine-purchase discount × 1.00

Company-type / offering discount × 0.50

Net insider selling penalty − 0

Why are they buying?

AI · ipo_offering · catalyst credible · documented

The purchases occurred directly in conjunction with the closing of Braveheart Bio, Inc.'s initial public offering on August 7, 2026, where directors, officers, and major shareholders acquired shares at the IPO price.

Braveheart Bio successfully raised over $382 million in its initial public offering and concurrently listed on the Nasdaq Global Market under the ticker BRVE.

Filing references and sources

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

13 Form 4 trades · 10 insiders Sign in to download CSV

Purchases in this cluster, grouped by insider, largest first
Date	Insider	Role	Shares	Price	Value	Flags	Filing
2026-08-07	Forbion Growth III Management B.V. history of Forbion Growth III Management B.V.'s purchases	10% owner	3,600,000	$18.00 avg	$64.8M	offering
2026-08-07	Forbion Growth III Management B.V.		1,920,000	$18.00	$34.6M	offering	SEC filing for Forbion Growth III Management B.V. (opens in a new tab)
2026-08-07	Forbion Growth III Management B.V.		1,680,000	$18.00	$30.2M	offering	SEC filing for Forbion Growth III Management B.V. (opens in a new tab)
2026-08-07	ORBIMED ADVISORS LLC history of ORBIMED ADVISORS LLC's purchases	Director	1,940,000	$18.00 avg	$34.9M	offering
2026-08-07	ORBIMED ADVISORS LLC		1,666,667	$18.00	$30.0M	offering	SEC filing for ORBIMED ADVISORS LLC (opens in a new tab)
2026-08-07	ORBIMED ADVISORS LLC		273,333	$18.00	$4.9M	offering	SEC filing for ORBIMED ADVISORS LLC (opens in a new tab)
2026-08-07	Chimovits Erez history of Chimovits Erez's purchases	Director	1,940,000	$18.00 avg	$34.9M	offering
2026-08-07	Chimovits Erez		1,666,667	$18.00	$30.0M	offering	SEC filing for Chimovits Erez (opens in a new tab)
2026-08-07	Chimovits Erez		273,333	$18.00	$4.9M	offering	SEC filing for Chimovits Erez (opens in a new tab)
2026-08-07	Andreessen Marc L history of Andreessen Marc L's purchases	10% owner	1,100,000	$18.00	$19.8M	offering	SEC filing for Andreessen Marc L (opens in a new tab)
2026-08-07	Murdoch Travis history of Murdoch Travis's purchases	CEO	83,333	$18.00	$1.5M	offering	SEC filing for Murdoch Travis (opens in a new tab)
2026-08-07	Viehbacher Christopher history of Viehbacher Christopher's purchases	Director	83,333	$18.00	$1.5M	offering	SEC filing for Viehbacher Christopher (opens in a new tab)
2026-08-07	Lubner David Charles history of Lubner David Charles's purchases	Director	55,555	$18.00	$1,000.0K	offering	SEC filing for Lubner David Charles (opens in a new tab)
2026-08-07	Rickey James Paul history of Rickey James Paul's purchases	CFO	27,777	$18.00	$500.0K	offering	SEC filing for Rickey James Paul (opens in a new tab)
2026-08-07	Malek David I history of Malek David I's purchases	Director	4,166	$18.00	$75.0K	offering	SEC filing for Malek David I (opens in a new tab)
2026-08-07	Anderson Michele A. history of Anderson Michele A.'s purchases	Other C-suite	1,111	$18.00	$20.0K	offering	SEC filing for Anderson Michele A. (opens in a new tab)
Total					$159.0M